| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. | J Clin Oncol | 2009 | 2.30 |
| 2 | Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism. | Eur J Clin Pharmacol | 2010 | 1.55 |
| 3 | Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials. | Eur J Cancer | 2010 | 1.06 |
| 4 | Gemcitabine and epirubicin plasma concentration-related excretion in saliva in patients with non-small cell lung cancer. | Ther Drug Monit | 2010 | 0.75 |
| 5 | Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC. | Ther Drug Monit | 2003 | 0.75 |